These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Second generation of targeted drugs. Practitioner; 1987 Feb; 231(1424):137-8. PubMed ID: 3500468 [No Abstract] [Full Text] [Related]
9. Relative cytotoxic activity of immunotoxins reactive with different epitopes on the extracellular domain of the c-erbB-2 (HER-2/neu) gene product p185. Boyer CM; Pusztai L; Wiener JR; Xu FJ; Dean GS; Bast BS; O'Briant KC; Greenwald M; DeSombre KA; Bast RC Int J Cancer; 1999 Aug; 82(4):525-31. PubMed ID: 10404066 [TBL] [Abstract][Full Text] [Related]
10. Immunotoxins for central nervous system malignancy. Youle RJ Semin Cancer Biol; 1996 Apr; 7(2):65-70. PubMed ID: 8740561 [TBL] [Abstract][Full Text] [Related]
11. EGF mutant receptor vIII as a molecular target in cancer therapy. Kuan CT; Wikstrand CJ; Bigner DD Endocr Relat Cancer; 2001 Jun; 8(2):83-96. PubMed ID: 11397666 [No Abstract] [Full Text] [Related]
12. Systemic immunotoxin therapy of cancer: advances and prospects. Wawrzynczak EJ Br J Cancer; 1991 Oct; 64(4):624-30. PubMed ID: 1911210 [No Abstract] [Full Text] [Related]
13. Clinical studies: solid tumors. Spitler LE Cancer Treat Res; 1988; 37():493-514. PubMed ID: 2908641 [No Abstract] [Full Text] [Related]
14. [Antibody-conjugated cytostatic drugs. Uses of monoclonal antibodies for new strategies in tumor therapy]. Renner C; Pfreundschuh M Fortschr Med; 1994 Oct; 112(29):399. PubMed ID: 8001887 [No Abstract] [Full Text] [Related]
15. Antibody drug conjugates - Trojan horses in the war on cancer. Iyer U; Kadambi VJ J Pharmacol Toxicol Methods; 2011; 64(3):207-12. PubMed ID: 21843648 [TBL] [Abstract][Full Text] [Related]
16. Potent and specific killing of human malignant brain tumor cells by an anti-transferrin receptor antibody-ricin immunotoxin. Zovickian J; Johnson VG; Youle RJ J Neurosurg; 1987 Jun; 66(6):850-61. PubMed ID: 3033171 [TBL] [Abstract][Full Text] [Related]
17. Treatment of murine EL4 leukemia in ascitic form with anti-Thy 1.2 specific immunotoxins. Marches R; Mota G; Margineanu M; Stavri H; Savi G; Nicolae M; Bancu A; Moraru I Neoplasma; 1990; 37(5):573-8. PubMed ID: 2234217 [TBL] [Abstract][Full Text] [Related]
18. Antitumor effects of ricin A chain immunotoxins prepared from intact antibodies and Fab' fragments on solid human Hodgkin's disease tumors in mice. Engert A; Martin G; Pfreundschuh M; Amlot P; Hsu SM; Diehl V; Thorpe P Cancer Res; 1990 May; 50(10):2929-35. PubMed ID: 1692251 [TBL] [Abstract][Full Text] [Related]